Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome

Metabolism: Clinical and Experimental

Volumn 56, Issue 7, 2007, Pages 992-997

  Toscani, Mariana ^a,b   Migliavacca, Raphaella ^a,b   Sisson de Castro, José Augusto ^a   Spritzer, Poli Mara ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN;

ABDOMINAL FAT; ADIPOSE TISSUE; ADULT; ANDROGEN BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; CORRELATION ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIRSUTISM; HOMEOSTASIS MODEL ASSESSMENET; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LABORATORY DIAGNOSIS; MENSTRUAL CYCLE; NUTRITIONAL ASSESSMENT; OBESITY; OBSERVATIONAL STUDY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RELIABILITY; RISK FACTOR; SCAPULA; SKINFOLD THICKNESS; TRUNCAL ADIPOSITY; TRUNK; WAIST CIRCUMFERENCE;

ADIPOSITY; ADOLESCENT; ADULT; DENSITOMETRY, X-RAY; FEMALE; HIRSUTISM; HUMANS; INSULIN RESISTANCE; PILOT PROJECTS; POLYCYSTIC OVARY SYNDROME; SKINFOLD THICKNESS; WAIST-HIP RATIO;

EID: 34250005953     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.03.006     Document Type: Article

References (43)

1. National Institutes of Health, National Heart, Lung, and and Blood Institute. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults. The evidence report (1998), NIH, NHLBI, Bethesda
2. Bjorntorp P. Body fat distribution, insulin resistance, and metabolic diseases. Nutrition 13 (1997) 795-803
3. World Health Organization. Obesity: preventing and managing the global epidemic. Report of WHO consultation (1998), WHO, Geneva
4. Després J.P., Lemieux I., and Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. Clin Rev 3 (2001) 716-720
5. Bosello O., and Zamboni M. Visceral obesity and metabolic syndrome. Obes Rev 1 (2000) 47-56
6. Mayes J.S., and Watson G.H. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev 5 (2004) 197-216
7. Donato G.B., Fuchs S.C., Oppermann K., Bastos C., and Spritzer P.M. Menopausal status is associated with central adiposity measured at different cut-offs of waist circumference and waist-to-hip ratio. Menopause 13 (2006) 280-285
8. Spritzer P.M., Poy M., Wiltgen D., Mylius L.S., and Capp E. Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements. Hum Reprod 16 (2001) 1340-1346
9. Ehrmann D.A. Polycystic ovary syndrome. N Engl J Med 352 (2005) 223-236
10. Ek I., Arner P., Ryden M., Holm C., et al. A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance. Diabetes 51 (2002) 484-492
11. Puder J.J., Varga S., Kraenzlin M., De Geyter C., Keller U., and Muller B. Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance. J Clin Endocrinol Metab 90 (2005) 6014-6021
12. Rosenfield R.L. Hirsutism. N Engl J Med 353 (2005) 2578-2588
13. Oliveira I.O., Lhullier C., Brum I.S., and Spritzer P.M. Gene expression of type 2 17beta-hydroxysteriod dehydrogenase in scalp hairs of hirsute women. Steroids 68 (2003) 641-649
14. Rice C.L., Cunningham D.A., Paterson D.H., and Lefcoe M.S. Arm and leg composition determined by computed tomography in young and elderly men. Clin Physiol 9 (1989) 207-220
15. Janssen I., Katzmarzyk P.T., and Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med 162 (2002) 2074-2079
16. Kamel E.G., McNeill G., and Van Wijk M.C.W. Usefulness of anthropometry and DXA in predicting intra-abdominal fat in obese men and women. Obes Res 8 (2000) 36-42
17. Dobbelsteyn C.J., Joffres M.R., MacLean D.R., and Flowerdew G. A comparative of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk. Int J Obes Relat Metab Disord 25 (2001) 652-661
18. Pouliot M.C., Despres J.P., Lemieux S., et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indices of abdominal visceral tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 74 (1994) 460-468
19. Ham T.S., van Leer E.M., Seidell J.C., and Lean M.E.J. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 311 (1995) 1401-1405
20. Glickman S.G., Marn C.S., Supiano M.A., and Dengel D.R. Validity and reliability of dual-energy X-ray absorptiometry for the assessment of abdominal adiposity. J Appl Physiol 97 (2004) 509-514
21. Kuczmarski R.J., Flegal K.M., Campbell S.M., and Johnson C.L. Increasing prevalence of overweight among U.S. adults: the National Health and Nutrition Examination Surveys, 1960 to 1991. J Am Med Assoc 272 (1994) 205-211
22. Velde S.J., Twisk J.W.R., van Mechelen W., and Kemper H.C.G. Birth weight, adult body composition, and subcutaneous fat distribution. Obes Res 11 (2003) 202-208
23. Marcus M.A., Murphy L., Pi-Sunyer F.X., and Albu J.B. Insulin sensitivity and serum triglyceride level in obese white and black women: relationship to visceral and truncal subcutaneous fat. Metabolism 48 (1999) 194-199
24. Spritzer P.M., Billaud L., Thalabard J.C., et al. Cytoproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia. J Clin Endocrinol Metab 70 (1990) 642-646
25. Azziz R., Dewailly D., and Owerbach D. Nonclassic adrenal hyperplasia: current concepts. J Clin Endocrinol Metab 78 (1994) 810-815
26. Comim F.V., and Spritzer P.M. Increased growth hormone response to clonidine in nonobese normoinsulinemic patients with polycystic ovary syndrome. Fertil Steril 81 (2004) 108-113
27. Mather K.J., Kwan F., and Corenblum B. Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity. Fertil Steril 73 (2000) 150-156
28. World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. World Health Organ Tech Rep Ser 854 (1995) 1-452
29. Ferriman D., and Gallwey J.D. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21 (1961) 1140-1148
30. World Heath Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: report of a WHO consultation: diagnosis and classification of diabetes mellitus (1999), WHO, Geneva
31. Ascaso J.F., Romero P., Real J.T., Priego A., Valdecabres C., and Carmena R. Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population. Med Clin (Barc) 117 (2001) 530-533
32. Faulkner J.A. Physiology of swimming and diving. In: Falls H. (Ed). Exercise physiology (1968), Academic Press, Baltimore 415-445
33. Maturana M.A., and Spritzer P.M. Association between hyperinsulinemia and endogenous androgen levels in peri- and postmenopausal women. Metabolism 51 (2002) 238-243
34. Oppermann K., Kohek M.B., Fuchs S.C., and Spritzer P.M. Association between hyperinsulinemia, endogenous androgens, and endometrial thickness in pre- and perimenopausal women: a population-based study. Gynecol Endocrinol 18 (2004) 269
35. Gambineri A., Pelusi C., Vicennati V., Pagotto U., and Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 26 (2002) 883-896
36. Toth M.J., Tchernof A., Sites C.K., and Poehlman E.T. Effect of menopausal status on body composition and abdominal fat distribution. Int J Obes Relat Metab Disord 24 (2000) 226-231
37. Legro R.S., Kunselman A.R., Dodson W.C., and Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84 (1999) 165-169
38. Woodrow G., Oldroyd B., Smith M.A., and Turney J.H. Measurement of body composition in chronic renal failure: comparison of skinfold anthropometry and bioelectrical impedance with dual energy X-ray absorptiometry. Eur J Clin Nutr 50 (1996) 295-301
39. Stall S.H., Ginsberg N.S., De Vita M.V., et al. Comparison of five body-composition methods in peritoneal dialysis patients. Am J Clin Nutr 64 (1996) 125-130
40. Evans E.M., Saunders M.J., Spano M.A., Arngrimsson S.A., Lewis R.D., and Cureton K.J. Body-composition changes with diet and exercise in obese women: a comparison of estimates from clinical methods and a 4-component model. Am J Clin Nutr 70 (1999) 5-12
41. Warner E.R., Fornetti W.C., Jallo J.J., and Pivarnik J.M. A skinfold model to predict fat-free mass in female athletes. J Athl Train 39 (2004) 259-262
42. Ingberg C.M., Sarnblad S., Palmer M., Schvarcz E., Berne C., and Aman J. Body composition in adolescent girls with type 1 diabetes. Diabet Med 20 (2003) 1005-1011
43. Lohman T.G., Pollock M.L., Slaughter M.H., Brandon L.J., and Broileau R.A. Methodological factors and the prediction of body fat in female athletes. Med Sci Sports Exerc 16 (1984) 92-96